Passage Bio Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Passage Bio's estimated annual revenue is currently $13.3M per year.(?)
  • Passage Bio's estimated revenue per employee is $155,000

Employee Data

  • Passage Bio has 86 Employees.(?)
  • Passage Bio grew their employee count by 161% last year.
  • Passage Bio currently has 16 job openings.

Passage Bio was launched with the vision to be a first in class fully-integrated genetic medicines company developing life transforming AAV-delivered in vivo therapeutics for the treatment of rare CNS diseases. In collaboration with the University of Pennsylvania Gene Therapy Program, Philadelphia-based Passage Bio plans to advance a portfolio of 6 rare disease indications in the neuro/CNS genetic space through IND-enabling studies using best-in-class AAV technology and know-how. Subsequently, Passage Bio will be responsible for all clinical development and will collaborate with Penn?s Orphan Disease Center to support these efforts.